SynCore Biotechnology Co Ltd banner
S

SynCore Biotechnology Co Ltd
TPEX:4192

Watchlist Manager
SynCore Biotechnology Co Ltd
TPEX:4192
Watchlist
Price: 19.5 TWD 0.26%
Market Cap: NT$685.6m

Wall St Price Targets

Price Targets Summary
SynCore Biotechnology Co Ltd

There are no price targets for SynCore Biotechnology Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
SynCore Biotechnology Co Ltd Competitors:
Price Targets
LE
Lands End Inc
60% Upside

Revenue
Forecast

N/A
Past Growth
-13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 11 years is -13%.

Gross Profit
Forecast

N/A
Past Growth
-14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 11 years is -14%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SynCore Biotechnology Co Ltd's stock price target?
Not Available

SynCore Biotechnology Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for SynCore Biotechnology Co Ltd?
Projected CAGR
-13%

The compound annual growth rate for Revenue over the next 11 years is -13%.

What is the Gross Profit forecast for SynCore Biotechnology Co Ltd?
Projected CAGR
-14%

The compound annual growth rate for Gross Profit over the next 11 years is -14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett